EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

circELP2 reverse‐splicing biogenesis and function as a pro‐fibrogenic factor by targeting mitochondrial quality control pathway

Songzi Zhang iD, Diwei Tu, Weili Liu, Ruiqiong Li, Mengqi Jiang, Xinglong Yuan, Jianlin Luan, Hongbo Li, Changjun Lv, Xiaodong Song iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Songzi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, China. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, MicroRNAs, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is considered as a chronic, fibrosing interstitial pneumonia with unknown mechanism. The present work aimed to explore the function, biogenesis and regulatory mechanism of circELP2 in pulmonary fibrosis and evaluate the value of blocking circELP2‐medicated signal pathway for IPF treatment. The results showed that heterogeneous nuclear ribonucleoprotein L initiated reverse splicing of circELP2 resulting in the increase of circELP2 generation. The biogenetic circELP2 activated the abnormal proliferation and migration of fibroblast and extracellular matrix deposition to promote pulmonary fibrogenesis. Mechanistic studies demonstrated that cytoplasmic circELP2 sponged miR‐630 to increase transcriptional co‐activators Yes‐associated protein 1 (YAP1) and transcriptional co‐activator with PDZ‐binding motif (TAZ). Then, YAP1/TAZ bound to the promoter regions of their target genes, such as mTOR, Raptor and mLST8, which in turn activated or inhibited the genes expression in mitochondrial quality control pathway. Finally, the overexpressed circELP2 and miR‐630 mimic were packaged into adenovirus vector for spraying into the mice lung to evaluate therapeutic effect of blocking circELP2‐miR‐630‐YAP1/TAZ‐mitochondrial quality control pathway in vivo. In conclusion, blocking circELP2‐medicated pathway can alleviate pulmonary fibrosis, and circELP2 may be a potential target to treat lung fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisMicroRNAsIntracellular Signaling Peptides and ProteinsAnimalsMiceAdaptor Proteins, Signal TransducingLungSignal TransductionTranscription Factors

Stichwörter der Autor:innen

YAP1/TAZcircRNAmiRNAmitochondrial quality control pathwaypulmonary fibrosis

Substanzen

Adaptor Proteins, Signal TransducingMicroRNAsTranscription FactorsElp2 protein, mouseIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, China.
  • Department of Cellular and Genetic Medicine, Binzhou Medical University, Yantai, China.
  • Department of Clinical Nursing, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, China.

ORCID-Profile: Songzi Zhang, Xiaodong Song

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Zhang, S., Tu, D., Liu, W., Li, R., Jiang, M., Yuan, X., Luan, J., Li, H., Lv, C., & Song, X. (2024). circELP2 reverse‐splicing biogenesis and function as a pro‐fibrogenic factor by targeting mitochondrial quality control pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18098

Vancouver

Zhang S, Tu D, Liu W, Li R, Jiang M, Yuan X, et al. circELP2 reverse‐splicing biogenesis and function as a pro‐fibrogenic factor by targeting mitochondrial quality control pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18098

BibTeX
@article{Zhang2024,
  author = {Zhang, Songzi and Tu, Diwei and Liu, Weili and Li, Ruiqiong and Jiang, Mengqi and Yuan, Xinglong and Luan, Jianlin and Li, Hongbo and Lv, Changjun and Song, Xiaodong},
  title = {circELP2 reverse‐splicing biogenesis and function as a pro‐fibrogenic factor by targeting mitochondrial quality control pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18098}
}
Kostenlos starten →